NSE - Free Realtime Quote INR

Ipca Laboratories Limited (IPCALAB.NS)

Compare
1,600.25 -14.10 (-0.87%)
As of 1:51 PM GMT+5:30. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Premchand Godha A.C. A., B. Com., CA Executive Chairman 123M -- 1946
Mr. Pranay Premchand Godha CEO, MD & Executive Director 65.23M -- 1972
Mr. Ajit Kumar Bhanwarlal Jain A.C.A., B.Sc. CFO, MD & Executive Director 84.44M -- 1955
Mr. Harish Pandurang Kamath Compliance Officer, Corporate Counsel & Company Secretary -- -- 1959
Mr. Prashant Premchand Godha Executive Director 69.76M -- 1975
Mr. Pawan Kothari Vice President of Operations -- -- 1965
Mr. Vishnu Saran Singh Kushwaha Vice President of Technical -- -- 1968
Mr. Sunil Ghai President of Marketing -- -- 1963
Mr. Sameer S. Tamhane Senior Vice President of Human Resources -- -- 1967
Dr. Ashok Kumar President of R&D - Chemicals -- -- 1954

Ipca Laboratories Limited

125, Kandivli Industrial Estate
Kandivli (West)
Mumbai, 400067
India
91 22 6210 5000 https://www.ipca.com
Sector:?
Healthcare
Full Time Employees:?
17,335

Description

Ipca Laboratories Limited, a pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company also provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, hematology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. It also exports its products worldwide. The company was incorporated in 1949 and is based in Mumbai, India.

Corporate Governance

Ipca Laboratories Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 8, 2024 at 10:59 AM UTC - November 12, 2024 at 12:00 PM UTC

Ipca Laboratories Limited Earnings Date

Recent Events

August 6, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers